Tuberculosis is a chronic, communicable granulomatous disease caused by the bacterium Mycobacterium tuberculosis. It primarily attacks the pulmonary system, though extrapulmonary sites like the spine, lymph nodes, and kidneys are also susceptible. Transmission occurs almost exclusively via the airborne route. When an individual with active pulmonary disease coughs, sneezes, speaks, or sings, they expel microscopic droplet nuclei containing the bacilli. These infectious droplets remain suspended in the air for hours, waiting to be inhaled by a susceptible host.
Once inhaled, these bacilli navigate past the upper airway defenses and settle deep within the terminal alveoli. The probability of transmission depends heavily on environmental factors, such as the concentration of infectious droplets in the air and the duration of exposure. Poorly ventilated rooms, overcrowded tenement housing, and enclosed hospital wards greatly accelerate the spread of the disease within Nigerian communities.
Upon inhalation of Mycobacterium tuberculosis, the body's immune system mounts a cellular defense. Macrophages engulf the bacilli, initiating an inflammatory response that wall off the bacteria into granulomas, or tubercles.
A common clinical misconception is that anyone with a positive tuberculin skin test is automatically infectious. In reality, individuals with latent infection pose zero transmission risk.
Pulmonary tuberculosis presents with a constellation of insidious, progressive systemic and respiratory symptoms. Nurses must systematically assess for these clinical indicators during home visits and clinic consultations:
Accurate diagnosis relies on a combination of history, physical examination, microbiological assays, and imaging.
Treating active tuberculosis requires a prolonged multidrug regimen to eradicate actively dividing bacilli while preventing the emergence of drug-resistant strains. The standard intensive phase relies on a combination of isoniazid, rifampicin, pyrazinamide, and ethambutol taken daily for two months, followed by a continuation phase of isoniazid and rifampicin for four months.
Because non-adherence leads to treatment failure and multidrug-resistant tuberculosis (MDR-TB), the World Health Organization advocates for Directly Observed Therapy (DOT). Under DOT, a trained healthcare worker or designated community treatment supporter watches the patient swallow every single dose of medication. This direct supervision bridges the gap between prescription and actual ingestion, safeguarding both the individual and the wider community.
Managing tuberculosis at home necessitates strict environmental controls to protect household contacts. The nurse must educate families on maximizing natural ventilation by keeping doors and windows wide open during daylight hours. Sunlight and fresh air rapidly dilute and destroy airborne droplet nuclei.
Patients should cover their mouths and noses with a tissue or handkerchief when coughing or sneezing, disposing of used materials properly. During the infectious intensive phase, patients should sleep alone in a well-ventilated room and limit visitors, especially young children and immunocompromised individuals, until sputum smears convert to negative.
Tuberculosis is a severe wasting disease that places high metabolic demands on the body. Malnutrition worsens clinical outcomes and prolongs recovery. Nurses must collaborate with dietitians and families to encourage high-protein, calorie-dense local foods that support tissue repair and immune function.
Patient education forms the cornerstone of adherence. Individuals must understand that feeling better after a few weeks of treatment does not mean the disease is cured. Stopping medication early allows dormant bacilli to multiply, leading to a relapse that is much harder to treat.
First-line anti-tuberculosis drugs carry significant potential adverse effects that can disrupt treatment. Nurses must monitor patients closely during home visits and clinic follow-ups:
| Medication | Common Adverse Effect | Nursing Intervention |
|---|---|---|
| Isoniazid | Peripheral neuropathy | Administer Vitamin B6 |
| Rifampicin | Red-orange body fluids | Reassure patient it is harmless |
| Ethambutol | Optic neuritis | Baseline and follow-up visual checks |